New advances in chemotherapeutic and supportive care agents for the management of breast cancer patients.
A breast cancer diagnosis can be frightening and confusing for patients. This session addressed the new chemotherapeutic and supportive care agents available for the management of patients with breast cancer and the side effects associated with these new agents. Administration, pharmacology, and toxicities were addressed. In addition to providing insight into prevention and management of side effects of treatment, the speakers provided information on new clinical trials and agents on the horizon for treating this very heterogeneous group of patients with cancer.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000451:nursing*; D017024:Chemotherapy, Adjuvant; D018572:Disease-Free Survival; D006801:Humans; D020360:Neoadjuvant Therapy / Q000379:methods*; D024802:Nurse's Role; D009730:Nursing Assessment; D009859:Oncology Nursing / Q000379:methods*; D012307:Risk Factors; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D014839:Vomiting / Q000139:chemically induced